AI assistant
Sending…
PRO MEDICUS LIMITED — Annual Report 2004
Aug 25, 2004
65579_rns_2004-08-25_7d02f0da-9434-4d82-bdc2-16e3d1117928.pdf
Annual Report
Open in viewerOpens in your device viewer
Appendix 4EPreliminary Final Report
1. Company details
| Name of entity | ι. συπραπγ ασιαπο | |||
|---|---|---|---|---|
| Pro Medicus Limited | ||||
| ABN or equivalentFinancial year endedcompany reference('current period') | Financial year ended('previous period') | |||
| 25 006 194 752 | 30 June 2004 | 30 June 2003 | ||
| 2. Results for announcement to the market | ||||
| ASXListingRulesRef | 2004A$'000 | |||
| 2.1 | Revenue from ordinary activities | 8,402 | ||
| % change up/(down) of revenue from ordinary activities fromthe previous corresponding period. | Down11.5% | |||
| 2.2 | to members | Profit/(Loss) from ordinary activities after tax attributable | 3,577 | |
| corresponding period | % change up/(down) of Profit/(Loss) from ordinary activitiesafter tax attributable to members from the previous | Down21.3% | ||
| 2.3 | Net Profit/(Loss) for the period attributable to members | 3,577 | ||
| period. | % change up/(down) of Net Profit/(Loss) for the periodattributable to members from the previous corresponding | Down21.3% |
| 2.4 | Dividends (distributions) | Amount persecurity | Frankedamount persecurity |
|---|---|---|---|
| Franked dividend amount per security | |||
| Final Dividend | 2.25c | 2.254 | |
| Interim dividend | 1.25c | 1.25c | |
| 2.5 | Record date for Final dividend | 20 September, 2004 | |
| Final dividend payment date | 4 October, 2004 | ||
+ See chapter 19 for defined terms
š
| 2.6 | Operating Results for the PeriodPro Medicus today reported an after tax profit of $3.577 million. This published resultfor the current period, including the fundamental error adjustment relating to thereversal of accrued income for a deferred contract [please refer Note 2(b) of theFinancial Statements], shows a reduction in profit before tax of $1.417m to $5.020m.After reversing the fundamental error adjustment back to 2003, the period in which itoccurred, Pro Medicus 2004 results showed the second most profitable year in itshistory. | ||
|---|---|---|---|
| During the past financial year, the company continued its focus on higher marginsoftware sales, e-health and services. Profit before tax to revenue from operatingactivities on published figures decreased to 63.5% (2003: 70.7%). However, afterreversing the fundamental error adjustment back to 2003, the period in which itoccurred, the results show profit before tax to revenue from operating activitiesincreased to 68.4% (2003: 66.3%) on these restated figures. | |||
| Promedicus.net, the company's e-health offering, continued its strong growth in boththe number of doctors registered as well as transaction volumes, which have nowexceeded 6 million, making promedicus.net the leading e-health provider in Australia.The network carried 2.4 million transactions for the year, a 27.8% increase on theprevious year. The company continued to maximise the value of promedicus.net byextending its use to non-radiology providers, a trend it anticipates will accelerate in the2005 financial year. It also intends to leverage its relationship with the 16,000 doctorson the network to promote its other products and services, including the recentlylaunched ProMed Clinical software. | |||
| Building on the success of the first digital imaging installation at Lake Imaging, thecompany has now installed the technology at 10 sites, importantly covering private,large corporate and public radiology providers. Due to the size and complexity ofthese negotiations, the company has experienced slightly longer than expected leadtimes for sales of these products, but the level of recent market interest reinforces thecompany's confidence that the efficiency and clinical benefits the technology offers willinevitably drive the radiology industry towards a fully digital environment.The company intends to focus on overseas expansion following the successfulinstallation and support of it's seventeen UK sites. It is now looking for furtherinternational opportunities for it's world class digital radiology integration technology. | |||
| 3. | Statement of financial performance | ||
| Please refer to the Statement of Financial Performance in the Annual Financial Report. | |||
| 4. | Statement of financial position | ||
| Please refer to the Statement of Financial Position in the Annual Financial Report. | |||
| 5. | Statement of cash flows | ||
| Please refer to the Statement of Cash Flows in the Annual Financial Report. | |||
| 6. | Details of Dividends | 2004$'000 | 2003$'000 |
| Final DividendA Final Dividend of 2.25 cents (2003: 2.0) per share fullyfranked will be paid on 4 October 2004.Current Year Interim | $2,250 | $2,000 | |
| An interim dividend of 1.25 cents (2003: 1.25) per sharefully franked was paid on 5 April 2004. | $1,250 | $1,250 |
+ See chapter 19 for defined terms
| No foreign sourced dividend or distribution is included in either the interim or finaldividends. | |||
|---|---|---|---|
| 7. | Dividend or Distribution reinvestment plansThere are no dividend or distribution reinvestment plans in operation. | ||
| 8. | Statement of Retained EarningsPlease refer Note 17 of Annual Financial Report attached | ||
| 9. | Net Tangible Assets per securityNet Tangible Assets per security | 2004$0.108 | 2003$0.105 |
| 10. | Details of entities over which control has been gained or lost during theperiodThere are no entities over which control has been gained or lost during the period. | ||
| 11. | Associates and joint venture entitiesThere are no associates or relevant joint ventures. | ||
| 12. | Other significant information needed by an investor to make an informedassessment of the entity's financial performance and financial position.Please refer to section 2.6 | ||
| 13. | Foreign Entity accounting standardsNot applicable | ||
| 14. | Commentary on results for the period.The earnings per security and the nature of any dilution aspects.Please refer Note 22 of the Annual Financial Report attached.Returns to shareholders including distributions and buy backs.Please refer to Note 5 of the Annual Financial Report attached.Significant features of operating performance.Please refer to section 2.6The results of segments that are significant to an understanding of the business.Please refer to Note 26 of the Annual Financial Report attached. | ||
| Discussion of trends in performance.Please refer to section 2.6 |
+ See chapter 19 for defined terms
| 15. | Audit Statement | ||
|---|---|---|---|
| This report is based on accounts to which one of the following applies.(Tick one). | |||
| $^+$ accountsThe "accounts have been subject tohavebeenTheaudited.review. | |||
| The accounts have not yet been accounts are inThethe.audited or reviewed.process of being audited orsubject to review. |
Date: 26 August 2004
Sign here:
Company Secretary
Geoffrey W. Holden Print name:
+ See chapter 19 for defined terms
More from PRO MEDICUS LIMITED
Regulatory Filings
2026
Jun 1
Regulatory Filings
2026
Jun 1
Call Transcript
2026
Jun 1
Major Shareholding Notification
2026
May 28
Regulatory Filings
2026
May 17
Board/Management Information
2026
May 17
Major Shareholding Notification
2026
Apr 12
Capital/Financing Update
2026
Apr 12
Capital/Financing Update
2026
Apr 7
Transaction in Own Shares
2026
Mar 31